293 related articles for article (PubMed ID: 37388731)
1. Murine models to study human NK cells in human solid tumors.
Parodi M; Astigiano S; Carrega P; Pietra G; Vitale C; Damele L; Grottoli M; Guevara Lopez ML; Ferracini R; Bertolini G; Roato I; Vitale M; Orecchia P
Front Immunol; 2023; 14():1209237. PubMed ID: 37388731
[TBL] [Abstract][Full Text] [Related]
2. Enhanced development of functional human NK cells in NOD-scid-IL2rg
Aryee KE; Burzenski LM; Yao LC; Keck JG; Greiner DL; Shultz LD; Brehm MA
FASEB J; 2022 Sep; 36(9):e22476. PubMed ID: 35959876
[TBL] [Abstract][Full Text] [Related]
3. Development of Humanized Mouse Models for Studying Human NK Cells in Health and Disease.
Shan L; Flavell RA; Herndler-Brandstetter D
Methods Mol Biol; 2022; 2463():53-66. PubMed ID: 35344167
[TBL] [Abstract][Full Text] [Related]
4. Purinergic targeting enhances immunotherapy of CD73
Wang J; Lupo KB; Chambers AM; Matosevic S
J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
[TBL] [Abstract][Full Text] [Related]
5. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.
Katano I; Takahashi T; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M
J Immunol; 2015 Apr; 194(7):3513-25. PubMed ID: 25712215
[TBL] [Abstract][Full Text] [Related]
6. The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models.
Maser IP; Hoves S; Bayer C; Heidkamp G; Nimmerjahn F; Eckmann J; Ries CH
Front Immunol; 2020; 11():2082. PubMed ID: 33013879
[TBL] [Abstract][Full Text] [Related]
7. Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.
Jan CI; Huang SW; Canoll P; Bruce JN; Lin YC; Pan CM; Lu HM; Chiu SC; Cho DY
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663641
[TBL] [Abstract][Full Text] [Related]
8. Real-Time Tracking of
Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
Front Immunol; 2018; 9():825. PubMed ID: 29770131
[TBL] [Abstract][Full Text] [Related]
9. Isolation and (111)In-Oxine Labeling of Murine NK Cells for Assessment of Cell Trafficking in Orthotopic Lung Tumor Model.
Malviya G; Nayak T; Gerdes C; Dierckx RA; Signore A; de Vries EF
Mol Pharm; 2016 Apr; 13(4):1329-38. PubMed ID: 26962716
[TBL] [Abstract][Full Text] [Related]
10. Humanized mouse model supports development, function, and tissue residency of human natural killer cells.
Herndler-Brandstetter D; Shan L; Yao Y; Stecher C; Plajer V; Lietzenmayer M; Strowig T; de Zoete MR; Palm NW; Chen J; Blish CA; Frleta D; Gurer C; Macdonald LE; Murphy AJ; Yancopoulos GD; Montgomery RR; Flavell RA
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9626-E9634. PubMed ID: 29078283
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2
Chu Y; Nayyar G; Jiang S; Rosenblum JM; Soon-Shiong P; Safrit JT; Lee DA; Cairo MS
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34244307
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
Greene S; Robbins Y; Mydlarz WK; Huynh AP; Schmitt NC; Friedman J; Horn LA; Palena C; Schlom J; Maeda DY; Zebala JA; Clavijo PE; Allen C
Clin Cancer Res; 2020 Mar; 26(6):1420-1431. PubMed ID: 31848188
[TBL] [Abstract][Full Text] [Related]
13. Human Hematopoietic Stem Cell Engrafted IL-15 Transgenic NSG Mice Support Robust NK Cell Responses and Sustained HIV-1 Infection.
Abeynaike SA; Huynh TR; Mehmood A; Kim T; Frank K; Gao K; Zalfa C; Gandarilla A; Shultz L; Paust S
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851579
[TBL] [Abstract][Full Text] [Related]
14. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
Kozlowska AK; Kaur K; Topchyan P; Jewett A
Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
[TBL] [Abstract][Full Text] [Related]
15. Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse.
Katano I; Nishime C; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M; Takahashi T
Sci Rep; 2017 Dec; 7(1):17230. PubMed ID: 29222435
[TBL] [Abstract][Full Text] [Related]
16. Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy.
Miller JS; Rooney CM; Curtsinger J; McElmurry R; McCullar V; Verneris MR; Lapteva N; McKenna D; Wagner JE; Blazar BR; Tolar J
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1252-7. PubMed ID: 24816582
[TBL] [Abstract][Full Text] [Related]
17. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
[TBL] [Abstract][Full Text] [Related]
18. Multiple Defects of Natural Killer Cells in Cancer Patients: Anarchy, Dysregulated Systemic Immunity, and Immunosuppression in Metastatic Cancer.
Jewett A; Kos J; Kaur K; Turnsek TL; Breznik B; Senjor E; Wong P; Nguyen KY; Ko MW
Crit Rev Immunol; 2020; 40(2):93-133. PubMed ID: 32749091
[TBL] [Abstract][Full Text] [Related]
19. Impact of Mixed Xenogeneic Porcine Hematopoietic Chimerism on Human NK Cell Recognition in a Humanized Mouse Model.
Li HW; Vishwasrao P; Hölzl MA; Chen S; Choi G; Zhao G; Sykes M
Am J Transplant; 2017 Feb; 17(2):353-364. PubMed ID: 27401926
[TBL] [Abstract][Full Text] [Related]
20. Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice.
Kübler A; Woiterski J; Witte KE; Bühring HJ; Hartwig UF; Ebinger M; Oevermann L; Mezger M; Herr W; Lang P; Handgretinger R; Münz C; André MC
Blood; 2014 Dec; 124(26):3914-23. PubMed ID: 25359989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
